Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement where Mdxhealth SA will acquire its Exosome Diagnostics Inc. business, including the ExoDx Prostate (EPI) test, CLIA-certified ...

Amsbio has introduced GenePORTER® Gold, a high-efficiency, lipid-based transfection reagent designed to deliver consistent ...

The company also announced it would be divesting its Exosome Diagnostics business and selling it to MDxHealth.

Enzymes, such as γ-secretase, are able to cleave and release the extracellular domain of BCMA into the bloodstream as soluble BCMA (sBCMA). It is also possible to shed sBCMA from the cell surface into ...

Objective SLE is a multisystem autoimmune disease characterised by chronic inflammation and progressive organ damage, ...